Intact Vascular recently secured an additional $20m to push the Tack Endovascular System to PMA approval. CEO Bruce Shook discusses the round, the potential for Tack, and shares that he&apos;s actually the CEO of TWO Medtech start-ups.

Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus

A weekly conversation with the innovators who will change how health care is delivered.